Cited by

• Therapeutic potential of myrrh and ivermectin against experimental Trichinella spiralis infection in mice.

  Basyoni MM, El-Sabaa AA. Basyoni MM, et al. Korean J Parasitol. 2013 Jun;51(3):297-304. doi: 10.3347/kjp.2013.51.3.297. Epub 2013 Jun 30. Korean J Parasitol. 2013. PMID: 23864740 Free PMC article.
• Decrease in adverse reactions after repeated ivermectin treatment in onchocerciasis.

  Van der Lelij A, Rothova A, Klaassen-Broekema N, Wilson WR, Barbe RF, Stilma JS. Van der Lelij A, et al. Doc Ophthalmol. 1990 Oct;75(3-4):215-24. doi: 10.1007/BF00164834. Doc Ophthalmol. 1990. PMID: 2090395
• Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.

  Dadzie KY, Bird AC, Awadzi K, Schulz-Key H, Gilles HM, Aziz MA. Dadzie KY, et al. Br J Ophthalmol. 1987 Feb;71(2):78-85. doi: 10.1136/bjo.71.2.78. Br J Ophthalmol. 1987. PMID: 3548811 Free PMC article. Clinical Trial.
• Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia.

  Kanza EM, Nyathirombo A, Larbelee JP, Opoku NO, Bakajika DK, Howard HM, Mambandu GL, Nigo MM, Wonyarossi DU, Ngave F, Kennedy KK, Kataliko K, Bolay KM, Attah SK, Olipoh G, Asare S, Mumbere M, Vaillant M, Halleux CM, Kuesel AC. Kanza EM, et al. Parasit Vectors. 2024 Mar 15;17(1):137. doi: 10.1186/s13071-023-06087-3. Parasit Vectors. 2024. PMID: 38491528 Free PMC article. Clinical Trial.
• Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement.

  Newland HS, White AT, Greene BM, D'Anna SA, Keyvan-Larijani E, Aziz MA, Williams PN, Taylor HR. Newland HS, et al. Br J Ophthalmol. 1988 Aug;72(8):561-9. doi: 10.1136/bjo.72.8.561. Br J Ophthalmol. 1988. PMID: 3046657 Free PMC article. Clinical Trial.